Bottom line
VHT vs HRTS: the short answer
VHT (Vanguard Health Care Index Fund) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 57% by weight.
But VHT is far broader, holding 407 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
VHT is cheaper at 0.09% vs 0.75% — a difference of $66 a year per $10,000 invested.
Over one year, HRTS returned +23.6% vs +2.7% for VHT (reporting dates differ).
Updated Nov 19, 2026
VHT vs HRTS side by side
| VHT | HRTS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Vanguard | Innovator |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.75% |
| Annual cost per $10k | $9 | $75 |
| 10-yr cost on $10k (prospectus) | $115 | $1,168 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.7% | +23.6% |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +8.8% | — |
| Best quarter | +16.5% | +15.8% |
| Worst quarter | −13.1% | −12.4% |
| Net assets (fund) | $19.0B | $51.9M |
| Number of holdings | 407 | 45 |
| Portfolio turnover | 4% | 4% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHT | HRTS | Difference |
|---|---|---|---|
| 2024 | +2.7% | +3.6% | −0.9% |
Source: Fund prospectus bar charts
Holdings overlap
15 of VHT's top 25 holdings also appear in HRTS's top 25.
| Holding | VHT | HRTS |
|---|---|---|
| Eli Lilly & Co | 14.04% | 11.52% |
| Johnson & Johnson | 8.47% | 3.59% |
| AbbVie Inc | 6.09% | 2.40% |
| UnitedHealth Group Inc | 5.45% | 5.24% |
| Merck & Co Inc | 4.66% | 4.27% |
| Thermo Fisher Scientific Inc | 2.93% | 3.97% |
| Amgen Inc | 2.87% | 1.91% |
| Gilead Sciences Inc | 2.64% | 3.43% |
| Abbott Laboratories | 2.35% | 2.61% |
| Bristol-Myers Squibb Co | 1.84% | 2.09% |
| Danaher Corp | 1.84% | 2.66% |
| Vertex Pharmaceuticals Inc | 1.80% | 2.93% |
| McKesson Corp | 1.45% | 1.71% |
| Regeneron Pharmaceuticals Inc | 1.00% | 1.67% |
| Edwards Lifesciences Corp | 0.79% | 1.75% |
Source: SEC Form N-PORT
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
FAQ
What is the difference between VHT and HRTS?
Which is cheaper, VHT or HRTS?
Should I own both VHT and HRTS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.